Artificial intelligence, as it stands today, isn’t cheap. The leaders in the field are spending tens of billions of dollars on chips, data centers and more, running up steep losses so far. That has ...
Abbott Laboratories (NYSE:ABT) has recalled several models of its Proclaim and Infinity implantable neurostimulation devices over concerns that an external controller device may not be able to switch ...